Skip Navigation

This Article
Right arrow Print PDF (1191K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Yansura, D.G.
Right arrow Articles by Caruthers, M.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yansura, D.G.
Right arrow Articles by Caruthers, M.H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1977, Vol. 4, No. 3 723-737
© 1977


Articles

Studies on gene control regions. III. Binding of synthetic and modified synthetic lac operator DNAs to lactose repressor*

D.G. Yansura, D.V. Goeddel, D.L. Cribbsand and M.H. Caruthers

Department of Chemistry, University of Colorado Boulder, CO 80309, USA

Received February 3, 1977.

Chemically synthesized lactose operator DNA was tested for binding with lactose repressor protein. These operator DNAs were found to (1) bind specifically to lactose SQ repressor as measured by release of binding with the inducing ligand isopropyl-ß-D-thiogalactoside, (2) have dissociation half-lives of 37 seconds (21 base-paired duplex) and 46 seconds (26 base-paired duplex) and (3) have dissociation half-lives with x86 repressor of 9 minutes (21 base-paired duplex) and 18 minutes (26 base paired duplex). Modified operators containing 5-bromodeoxyuridine and deoxyuridine at specific sites were also prepared. These analogs bound both repressors about as tightly as the wild type sequence.


*This is paper III in a series on "Studies on Gene Control Regions". Paper II is ref. 3. This work was supported by grants from the National Institutes of Health (GM 21120 and GM 21644), a Cottrell Research Grant from Research Corporation, the National Science Foundation (PCM 76-01489), a Biomedical Sciences Support Grant from the National Institutes of Health to the University of Colorado, a National Science Foundation equipment grant (BMS 75-14541) and the University of Colorado. M.H.C. was supported by a Career Development Award from the National Institutes of Health (1 K04 GM 00076).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.